MiMedx Group, Inc. (MDXG)
NASDAQ: MDXG · Real-Time Price · USD
4.450
+0.110 (2.53%)
At close: Aug 19, 2026, 4:00 PM EDT
4.449
-0.001 (-0.02%)
After-hours: Aug 19, 2026, 7:59 PM EDT

MiMedx Group Revenue

MiMedx Group had revenue of $64.36M in the quarter ending June 30, 2026, a decrease of -34.73%. This brings the company's revenue in the last twelve months to $355.17M, down -2.36% year-over-year. In the year 2025, MiMedx Group had annual revenue of $418.63M with 19.99% growth.

Revenue (ttm)
$355.17M
Revenue Growth
-2.36%
P/S Ratio
1.83
Revenue / Employee
$439,571
Employees
808
Market Cap
648.63M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025418.63M69.75M19.99%
Dec 31, 2024348.88M27.40M8.52%
Dec 31, 2023321.48M53.64M20.03%
Dec 31, 2022267.84M25.82M10.67%
Dec 31, 2021242.02M-6.22M-2.50%
Dec 31, 2020248.23M-51.02M-17.05%
Dec 31, 2019299.26M-59.86M-16.67%
Dec 31, 2018359.11M37.97M11.82%
Dec 31, 2017321.14M99.43M44.85%
Dec 31, 2016221.71M34.42M18.38%
Dec 31, 2015187.30M69.07M58.43%
Dec 31, 2014118.22M59.04M99.77%
Dec 31, 201359.18M32.13M118.76%
Dec 31, 201227.05M19.29M248.60%
Dec 31, 20117.76M6.97M883.74%
Dec 31, 2010788.87K--
Mar 31, 2009---
Mar 31, 2008---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
CorMedix462.25M
Arvinas316.70M
Valneva SE163.30M
Zevra Therapeutics136.07M
4D Molecular Therapeutics92.01M
Verastem87.53M
Assembly Biosciences74.85M
Revenue Rankings